The Effect of Virtual Reality Application Diagnosed With Myocardial Infarction

The Effect of Virtual Reality on Vital Signs and Anxiety in Myocardial Infarction Patients Admitted to Cardiology Intensive Care Unit: A Randomized Controlled Study.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07696390

Enrollment

Registered

2026-07-10

Start date

2026-07-10

Completion date

2026-09-18

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

Myocardial infarction, virtual reality, vital signs, stress

Brief summary

This study was designed to investigate the effects of VR (virtual reality) glasses on vital signs and anxiety in conscious patients diagnosed with myocardial infarction and admitted to the cardiology intensive care unit.

Detailed description

This study was designed to investigate the effects of VR (virtual reality) glasses on vital signs and anxiety in conscious patients with myocardial infarction (MI) admitted to the cardiology intensive care unit. Studies examining the psychological (anxiety) and physiological (vital signs) effects of VR application on MI patients in cardiology intensive care units are quite limited. In this context, this study aims to examine the effects of VR glasses application on the vital signs (blood pressure, heart rate, SPO2, respiratory rate) and anxiety levels of MI patients in intensive care, within the framework of a randomized experimental design. The data obtained are expected to make significant contributions to the integration of technological interventions into cardiovascular disease management.

Interventions

OTHERvirtual reality glasses

Participants will be shown a video with nature images through virtual reality glasses, and their vital signs and anxiety levels will be measured.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE (Outcomes Assessor)

Masking description

Outcomes Assessor does not know whether patients are in the experimental group or the control group.

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

1. The patient is in intensive care. 2. The patient has been diagnosed with myocardial infarction. 3. The patient is between 18 and 70 years old. 4. The patient is conscious. 5. The patient is oriented and cooperative. 6. The patient volunteers to participate in the study. 7. The patient is open to communication. 8. The patient agrees to participate in the study. 9. The patient has no mental, visual, auditory, or speech impairment. 10. The patient has undergone stent placement. 11. The patient has STEMI.

Exclusion criteria

1. The patient has a psychiatric disorder. 2. The patient has any communication impairment.

Design outcomes

Primary

Measure	Time frame	Description
Anxiety Level	Periprocedural	The patient's anxiety level will be measured using the State Anxiety Scale (STAI Form TX-1).
Vital Signs - Blood pressure measurements (SBP, DBP)	Periprocedural	Blood pressure measurements (SBP, DBP)
Vital Signs- heart rate	Periprocedural	heart rate will be taken.
Vital Signs - respiratory rate per minute	Periprocedural	respiratory rate per minute will be taken.

Countries

Turkey (Türkiye)

Contacts

CONTACTYavuz Uren, Asst.Prof.

yavuzuren@yyu.edu.tr+905065961050

CONTACTAyşe Özturk, MSc student

yavuzuren@yyu.edu.tr+905395934634

STUDY_CHAIRYavuz Uren, Asst.Prof

Van Yuzuncu Yil Universty

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 14, 2026